Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6077
Source ID: NCT00474838
Associated Drug: Intensive Insulin Group
Title: Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy
Acronym: KIIT
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus|Pancreatic Beta Cell Function|Glucotoxicity
Interventions: DRUG: intensive insulin group|DRUG: Oral AntiDiabetic Drug (glimepiride and metformin)
Outcome Measures: Primary: Long-term glycemic control, up to 2 years|Change of pancreatic beta cell function, up to 2 years | Secondary: Inflammatory marker and insulin sensitivity, up to 2 years|Time to reach target goal of blood glucose level, up to 2 year
Sponsor/Collaborators: Sponsor: Kyunghee University Medical Center | Collaborators: Korea University Guro Hospital|Hanyang University|Inha University Hospital|Ajou University|Sanofi|East West Neo Medical Center|The Catholic University of Korea|Jeju National University Hospital
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 112
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2007-04
Completion Date: 2012-12
Results First Posted:
Last Update Posted: 2013-09-26
Locations: Hanyang University Medical Center, Kuri, Kyunggi-do, 471-020, Korea, Republic of|The Catholic University of Korea Bucheon St.Mary's Hospital, Bucheon, Korea, Republic of|Inha University Hospital, In Cheon, 400-711, Korea, Republic of|Jeju National University Hospital, Jeju-do, Korea, Republic of|Kyunghee University Medical Center, Seoul, 130-702, Korea, Republic of|Korea University Guro Hospital, Seoul, 152-730, Korea, Republic of|Kyung Hee University East Weast Neo Medicalcenter, Seoul, Korea, Republic of|Ajou University Medical Center, Suwon, 443-721, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT00474838